Theralizumab Biosimilar - Research Grade, Low Endotoxin

Theralizumab Biosimilar - Research Grade, Low Endotoxin

Catalog Number:
A001437406ICH
Mfr. No.:
ICH5023
Price:
$560
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Specificity: Detects human CD28. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Theralizumab.
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Bulk Human IgG4 Isotype Control (IB4) [ICH2257]
          Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method

          Please contact us at for specific academic pricing.

          Background

          Theralizumab GN1412 is a humanised monoclonal antibody that not only binds to, but is a strong agonist for, the CD28 receptor of the immune system’s T cells. CD28 is the co-receptor for the T cell receptor; It binds to receptors on the interacting partner in the reaction through one of its ligands (B7 family). It was withdrawn from development after inducing severe inflammatory reactions as well as chronic organ failure in the first-in-human study by PAREXEL in London in March 2006.

      • Properties
        • Isotype
          IgG4
          Reactivity
          human
          Purification
          >95% by SDS-PAGE
          Formulation
          Sterile, preservative-free, solution in PBS. BSA and Azide free.
          Storage
          This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
          Molecular Weight
          5mg/ml
          Antigen

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Functional Assays

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.